
    
      Treatment is planned with carboplatin AUC 5 given IV on day 1 and liposomal doxorubicin 40
      mg/m2 given IV on day 1, with treatment repeated every 28 days. Delays in treatment
      administration and dose reductions have been planned according to toxicity.
    
  